First Chikungunya Vaccine Now FDA Approved — What To Know About The ‘Emerging Global Health Threat’

Forbes November 10, 2023
Robert Hart

Topline

The Food and Drug Administration on Thursday approved the world’s first vaccine for chikungunya, a mosquito-borne virus with similar symptoms to dengue and Zika that experts warn is a major global health threat that the climate crisis is propelling to new parts of the world, including the United States.

Key Facts

News Peg

The FDA said it had approved the first chikungunya vaccine for use in adults ages 18 and older who are at high risk of catching the virus. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said the approval “addresses an unmet medical need and is an important advancement in the prevention of a potentially debilitating disease with limited treatment options.” The shot,...

Today's Sponsors

Today's Sponsor